Tyco launches SHPI (Specialised Health Products International) safety syringe range in US:
This article was originally published in Clinica
Tyco International's Kendall unit has begun the US launch of Specialised Health Products International's (SHPI) line of safety syringe needles. The range will be sold under the brand name Monoject Magellan. The US safety needle and syringe market is worth some $260 million, the companies say. For SHPI, the development marks the first commercial product available based on its proprietary FlexLoc technology. Kendall's Safety Syringe Corporation will oversee integration of the Flexloc technology for safety blood collection. This market is valued in the US at some $130 million annually.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.